Pharmacy Medical News about Patient Simulation Nonprescription Drugs

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Simulated patient visits with immediate feedback to improve the supply of over-the-counter medicines: a feasibility study
Family Practice, 10/15/09

Watson MC et al. – Simulated patient (SP) visits with feedback were acceptable to pharmacists as a method of improving the quality of consultations for OTC medicines, irrespective of the person giving feedback (SP or PE). The process by which pharmacists and their staff derived their recommendations, in terms of information gathering, could be improved. A large–scale study is needed to assess the effectiveness and cost–effectiveness of SP visits with feedback.

Exclusive Author Commentary
Margaret C. Watson, 10/20/09

This study is part of a research programme to explore influences on consultations for nonprescription medicines and to develop strategies and interventions to improve the safe and effective supply of these medicines. With the increasing number of medicines available for purchase in many countries, it's important to maximise their effective use whilst minimisiing risk. Simulated patient visits combined with immediate feedback is one method of providing an in situ educational intervention to improve professional practice. The results of this study show that this method of education was acceptable to pharmacists. In addition, the results showed that whilst most consultations resulted in an appropriate outcome i.e. appropriate supply or non-supply of a medicine, the process for determining the recommendation to supply or not supply was often deficient. The results of this study will be used to inform a definitive randomised controlled trial of this intervention as a method of improving the quality of practice in community pharmacy in the UK.

<< Previous
Solifenacin for Overactive Bladder: Patient-Reported Outcomes...

Next >>
A retrospective evaluation of the impact of total smoking...

Development of a drug–disease simulation model for rituximab in follicular non-Hodgkin's lymphoma
British Journal of Clinical Pharmacology, 10/22/09 Relevance Score: 79%

Comparative Pharmacodynamics of Intermittent and Prolonged Infusions of Piperacillin/Tazobactam Using Monte Carlo Simulation and Steady-State Pharmacokinetic Data from Hospitalized Patients (November)
Annals of Pharmacotherapy, 10/15/09 Relevance Score: 79%

A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09 Relevance Score: 78%

Computer Simulations Validate Treatment Targets For Lung Cancer
ScienceDaily, 10/13/09 Relevance Score: 78%

Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological center: two years drug survival
Rheumatology International, 10/14/09 Relevance Score: 70%